A carregar...
PARP inhibitors in ovarian cancer: Clinical evidence for informed treatment decisions
Ovarian cancer is the fifth leading cause of female cancer deaths in the Western world. Significant progress has been made in the treatment of patients with ovarian cancer, however, the majority of patients experience disease recurrence and new therapies are being sought for such patients. Clinical...
Na minha lista:
| Publicado no: | Br J Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4816268/ https://ncbi.nlm.nih.gov/pubmed/26669450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.395 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|